Limited prognostic value of dual time point F-18 FDG PET/CT in patients with early stage (stage i & II) non-small cell lung cancer (NSCLC)

Radiotherapy and Oncology

Volumn 98, Issue 1, 2011, Pages 105-108

  Kim, Seong Jang ^a   Kim, Yong Ki ^b   Kim, In Joo ^a   Kim, Young Dae ^a,c   Lee, Min Ki ^a,c  

^a Pusan National University School of Medicine   (South Korea)

^b Private Clinic of Endocrinology and Metabolism and Nuclear Medicine   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

Disease free survival; Dual time point; F 18 FDG; Non small cell lung cancer; Overall survival

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78651350630     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.11.007     Document Type: Article

References (21)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 549
2. N. Martini, M.S. Bains, and M.E. Burt Incidence and local recurrence and second primary tumors in resected stage I lung cancer J Thorac Cardiovasc Surg 109 1995 120 129
3. T. Goya, H. Asamura, and H. Yoshimura Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study Lung Cancer 50 2005 227 234 (Pubitemid 41427898)
4. D.H. Harpole Jr., J.E. Herndon 2nd, W.G. Young Jr., W.G. Wolfe, and D.C. Sabiston Jr. Stage I non-small cell lung cancer: a multivariate analysis of treatment methods and patterns of recurrence Cancer 76 1995 787 796
5. D.E. Williams, P.C. Pairolero, and C.S. Davis Survival of patients surgically treated for stage I lung cancer J Thorac Cardiovasc Surg 82 1981 70 76 (Pubitemid 11053014)
6. J.P. Wisnivesky, C. Henschke, T. McGinn, and M.C. Iannuzzi Prognosis of stage II non-small cell lung cancer according to tumor and nodal status at diagnosis Lung Cancer 49 2005 181 186 (Pubitemid 40966745)
7. C.F. Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717 (Pubitemid 27260107)
8. J. Moldvay, P. Scheid, and P. Wild Predictive survival markers in patients with surgically resected non-small cell lung carcinoma Clin Cancer Res 6 2000 1125 1134 (Pubitemid 30159376)
9. Baardwijk Angela van, Bosmans Geert, and Dekker André Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients Radiother Oncol 82 2007 145 152 (Pubitemid 46298778)
10. Senft Asaf, Bree Remco de, and Otto S. Hoekstra Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial Radiother Oncol 87 2008 221 229
11. 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer Radiother Oncol 55 2000 371 424
12. 18F]FDG-PET) voxel intensity-based intensity-modulated radiotherapy (IMRT) for head and neck cancer Radiother Oncol 79 2006 249 258
13. Marco H.M. Janssen, Michel C. Öllers, and Ruud G.P.M. van Stiphout Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET/CT findings Radiother Oncol 94 2010 151 155
14. Ruysscher Dirk De, and Kirsch Carl-Martin PET scans in radiotherapy planning of lung cancer Radiother Oncol 96 2010 335 338
15. A. Mavi, S. Basu, and T.F. Cermik Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease Mol Imaging Biol 11 2009 369 378
16. R. Tian, M. Su, and Y. Tian Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions Skeletal Radiol 38 2009 451 458
17. 18F- fluoro-2-deoxy-d-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer Eur J Nucl Med Mol Imaging 32 2005 389 397 (Pubitemid 40591169)
18. M. Houseni, W. Chamroonrat, J. Zhuang, R. Gopal, A. Alavi, and H. Zhuang Prognostic implication of dual-phase PET in adenocarcinoma of the lung J Nucl Med 51 2010 535 542
19. B. Sanghera, W.L. Wong, and M.A. Lodge Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer Nucl Med Commun 26 2005 861 867 (Pubitemid 41426547)
20. 18F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer J Nucl Med 43 2002 173 180 (Pubitemid 34151039)
21. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax J Nucl Med 44 2003 540 548 (Pubitemid 39663420)